A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Pregabalin in Subjects With Generalized Anxiety Disorder (GAD) Switching From Benzodiazepine Therapy.
Phase of Trial: Phase III
Latest Information Update: 19 Oct 2012
At a glance
- Drugs Pregabalin (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- 19 Oct 2012 Planned number of patients changed from 80 to 120.
- 15 Sep 2009 Results presented at the 22nd Annual Congress of the European College of Neuropsychopharmacology.
- 12 Nov 2008 Status changed from recruiting to completed, as reported by clinicaltrials.gov.